Abstract:Objective: To evaluate correlation between chemosensitivity of tumor cells in vitro and their clinical responsive- ness in vivo by comparing the difference of curative effect between chemotherapy of cerebral gliomas directed by chemo- sensitivity test in vitro and its routine chemotherapy. Methods: Sixty-two patients with cerebral gliomas were recruited as the experiment group, who had received total resection or subtotal resection of the tumor. The resected tumor cells were cultured in vitro, followed by chemosensitivity test using colorimetric MTT assay. Finally, chemotherapeutic protocol was made based on the results of the chemosensitivity test. Fifty patients with cerebral gliomas subjected to the routine chemotherapeutic protocol were simultaneously recruited as the control group, whose age, gender, survival functional status and operational fashion were matched with the experiment group. The two groups were equally followed up for the survival functional status, recurrence and death. All data were analyzed using SPSS 10.0 software. Results: At the time of evaluation, KPS values of 64.52 ± 35.84 were seen in the experiment group, and 33.60 ± 36.24 in the control group, showing statistical difference between the two groups （t = 4.5163, P = 0.000）. During 2–4 years of follow up, a recurrence rate of 32.26% was seen in the experimental group, and 60.00% in the control group, showing a statistical difference between the two groups （χ2 = 8.620, P = 0.003）. The fatality was 22.58% in the experiment group, and 48.00% in the control group, showing a statistical difference between the two groups （χ2 = 7.978, P = 0.005）. The survival rate of the experimental group was higher than that of the control group, showing a statistical differences between the two groups （χ2 = 7.29, P = 0.0069）. Conclusion: Chemotherapy of glio- mas under the guidance of chemosensitivity test in vitro contributes to obvious improvement on the current survival functional status, a clear decline of the recurrence rates and fatality rate, and raised survival rates of the patients. A close correlation between the chemosensitivity in vitro and clinical responsiveness in vivo is observed.

Research on the chemotherapeutic sensitivity of cerebral gliomas

Research on the Chemotherapeutic Sensitivity of Cerebral Gliomas in Vitro

Study on the Sensitivity of Primary Glioma Cell to Chemotherapeutic Agents in Vitro

Chemosensitivity of Human Glioma in Vitro by MTT Method

[Study on Sensitivity of Neuroglioma to Chemotherapeutic Drugs].

Experimental Study on the Anti - Cancer Drugs' Sensitivity in the Colormetric Assay of Cancer Cells with MTT and Its Effective Factors

An Evaluation of the Sensitivity of Chemotherapeutical Agents to Breast Cancer by MTT Assay in Vitro

Chemotherapy of Cerebral Gliomas Directed by the Chemosensitivity Test in Vitro: a Clinical Study

Research and Exploratory of Chemotherapy Drugs Sensitivity Tests in Liver Cancer

MTT measuring drug sensitivity of cancer cells and its relationship with clinical prescription

Clinical Study on Sensitivity of Oral and Maxillofacial Cancers with Chemotherapy

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

Sensitivity of different human colorectal tumor cell lines to commonly used chemotherapeutic drugs in vitro

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Predictive chemotherapy according to O6-methylguanine-DNA methyltransferase protein expression for malignant gliomas

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

Study on Chemosensitivity of Peripheral Blood Lymphocytes and Tumor Cells of Tumor Patients in Vitro

Analysis on the Detected Chemotherapeutic Drug Sensitivity Results of Gastric Cancer Cells by Using MTT Method

Clinical analysis of superselective interventional chemotherapy for malignant glioma patients based on in vitro chemosensitivity assay

Individualized chemotherapy based on in vitro chemotherapy sensitivity and resistance assays and molecular characteristics in patients with malignant gliomas.

Drug Susceptibility Test in Carcinoma of Gallbladder and Cholangiocarcinoma